Citigroup
CGNT

Citigroup’s Cogentix Medical, Inc. CGNT Stock Holding History

Citigroup’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-40
Closed – – 7906
2018
Q1 		$0 Buy
+40
New +$125 ﹤0.01% 7791
2016
Q3 		– Sell
-40
Closed – – 7303
2016
Q2 		$0 Hold
40
– – ﹤0.01% 7700
2016
Q1 		$0 Hold
40
– – ﹤0.01% 7995
2015
Q4 		$0 Hold
40
– – ﹤0.01% 8073
2015
Q3 		$0 Hold
40
– – ﹤0.01% 8014
2015
Q2 		$0 Buy
+40
New +$65 ﹤0.01% 7929

Citigroup's CGNT Position: Q2 2018 in Review

Citigroup sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 40 shares.

Citigroup first reported a position in CGNT in Q2 2015 and held it in 6 quarters. The position peaked at $0 in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

  • Citigroup reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
  • Citigroup sold 40 Cogentix Medical, Inc. shares in Q2 2018.
  • Citigroup first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 6 quarters.
  • Citigroup's Cogentix Medical, Inc. position peaked at $0 in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Citigroup's 13F filing for Q2 2018, filed 10 Aug 2018.